Journals
Publish with us
Publishing partnerships
About us
Blog
Gastroenterology Research and Practice
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Gastroenterology Research and Practice
/
2014
/
Article
/
Tab 1
/
Research Article
New Evidence on the Impact of Antithrombotics in Patients Submitted to Small Bowel Capsule Endoscopy for the Evaluation of Obscure Gastrointestinal Bleeding
Table 1
Baseline patients’ characteristics and antithrombotic use.
Characteristics,
(%)
Age (y), median (range)
61.9 (19–91)
Female
170 (62.0)
Occult OGIB
225 (82.1)
Visible OGIB
49 (17.9)
Hemoglobin (g/dL), median (range)
9.3 (4.2–15.1)
Diabetes mellitus
79 (28.8)
Chronic kidney disease
29 (10.6)
Arterial hypertension
140 (51.1)
Ischaemic heart disease
54 (19.7)
Antithrombotic drug use,
(%)
Antithrombotics
104 (38.0)
Antiplatelet alone
60 (21.9)
Aspirin
45 (16.4)
Thienopyridine
11 (4.0)
Both
4 (1.5)
Anticoagulant alone
31 (11.3)
Heparin/LMWH
15 (5.4)
Warfarin/acenocoumarol
16 (5.8)
Both
13 (4.7)